102 related articles for article (PubMed ID: 14509920)
1. The new anti-oncogene clusterin and the molecular profiling of prostate cancer progression and prognosis.
Bettuzzi S
Acta Biomed; 2003 Aug; 74(2):101-4. PubMed ID: 14509920
[No Abstract] [Full Text] [Related]
2. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
[TBL] [Abstract][Full Text] [Related]
3. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1.
Scaltriti M; Santamaria A; Paciucci R; Bettuzzi S
Cancer Res; 2004 Sep; 64(17):6174-82. PubMed ID: 15342402
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer.
Miyake H; Yamanaka K; Muramaki M; Kurahashi T; Gleave M; Hara I
Oncol Rep; 2005 Nov; 14(5):1371-5. PubMed ID: 16211311
[TBL] [Abstract][Full Text] [Related]
5. Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression.
Miyake H; Hara I; Kamidono S; Gleave ME; Eto H
Oncol Rep; 2003; 10(2):469-73. PubMed ID: 12579291
[TBL] [Abstract][Full Text] [Related]
6. Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.
Scaltriti M; Brausi M; Amorosi A; Caporali A; D'Arca D; Astancolle S; Corti A; Bettuzzi S
Int J Cancer; 2004 Jan; 108(1):23-30. PubMed ID: 14618611
[TBL] [Abstract][Full Text] [Related]
7. ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Fritzsche FR; Jung M; Tölle A; Wild P; Hartmann A; Wassermann K; Rabien A; Lein M; Dietel M; Pilarsky C; Calvano D; Grützmann R; Jung K; Kristiansen G
Eur Urol; 2008 Nov; 54(5):1097-106. PubMed ID: 18061337
[TBL] [Abstract][Full Text] [Related]
8. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
Miyake H; Hara I; Gleave ME; Eto H
Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
[TBL] [Abstract][Full Text] [Related]
9. Dys-regulation of clusterin in human hepatoma is not associated with tumorigenesis but is secondary to cell response to external tresses.
Hsieh SY; Chen WY; Shih TC; Yeh JY; Jeng JT
Mol Carcinog; 2005 Jun; 43(2):100-7. PubMed ID: 15791650
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.
Xie D; Lau SH; Sham JS; Wu QL; Fang Y; Liang LZ; Che LH; Zeng YX; Guan XY
Cancer; 2005 Jan; 103(2):277-83. PubMed ID: 15578711
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Cooper C
Eur Urol; 2008 Nov; 54(5):1107-8. PubMed ID: 18061340
[No Abstract] [Full Text] [Related]
12. Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Valentini A; Bernardini S
Eur Urol; 2008 Nov; 54(5):1106-7. PubMed ID: 18061338
[No Abstract] [Full Text] [Related]
13. Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoptosis in prostate and bladder cancer cells.
Wu AJ; Park II; Zhaung L; Lee C
Prostate; 2002 Dec; 53(4):277-85. PubMed ID: 12430139
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
15. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
[TBL] [Abstract][Full Text] [Related]
16. Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study.
Bettuzzi S; Scaltriti M; Caporali A; Brausi M; D'Arca D; Astancolle S; Davalli P; Corti A
Cancer Res; 2003 Jul; 63(13):3469-72. PubMed ID: 12839927
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
[TBL] [Abstract][Full Text] [Related]
18. Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression.
Bettuzzi S; Scorcioni F; Astancolle S; Davalli P; Scaltriti M; Corti A
Oncogene; 2002 Jun; 21(27):4328-34. PubMed ID: 12082621
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis.
Agalliu I; Lin DW; Salinas CA; Feng Z; Stanford JL
Prostate; 2006 Oct; 66(14):1535-41. PubMed ID: 16921513
[TBL] [Abstract][Full Text] [Related]
20. Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin.
Caccamo AE; Scaltriti M; Caporali A; D'Arca D; Scorcioni F; Astancolle S; Mangiola M; Bettuzzi S
Biochem J; 2004 Aug; 382(Pt 1):157-68. PubMed ID: 15139853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
